Navigation Links
Helper T cells, not killer T cells, might be responsible for clearing hepatitis A infection
Date:7/16/2012

Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Experimental Medicine.

Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. Despite the availability of an effective vaccine, the virus infects millions of people worldwide each year and remains a global public health problem, especially in underdeveloped countries.

Unlike the hepatitis C virus, the hepatitis A virus does not establish a persistent infection. Yet, up to 20 percent of patients can relapse several weeks after virus growth and after symptoms have disappeared.

"Mechanisms of immunity that protect against relapse, and why they occasionally fail, are unknown," said the study's lead author Christopher M. Walker, PhD, director of the Center for Vaccines and Immunity at The Research Institute at Nationwide Children's Hospital.

Research has shown that white blood cells known as CD8+ killer T cells play a critical role in controlling hepatitis C and hepatitis B virus infections. These T cells act by killing infected liver cells, a process that damages the liver, but is necessary to effectively shut off production of new viruses.

A study published more than 20 years ago suggested that killer T cells also control hepatitis A virus infection in humans. However, Dr. Walker observed a very different pattern of immunity while studying acute hepatitis A virus infection in animals.

He found that the infection was controlled well before an effective killer T cell response was generated. Hepatitis A virus growth was instead controlled by CD4+ T helper cells, a different type of white blood cell that normally assists in the activation killer T cells but, is not thought to directly engage virus-infected cells. In the two infected animals infected with the hepatitis A virus, helper T cells secreted factors that suppressed virus growth without causing serious liver damage or inflammation that is an undesirable byproduct of a killer T cell response.

Moreover, the helper T cells responded to resurgence in hepatitis A virus growth after initial control of the infection, and remained strong until the virus was finally eliminated from the liver several months later. These findings suggested that CD8+ T cells are not necessarily required to control hepatitis A virus infection. Instead, it appears that CD4+ T cells have a more direct role in stopping replication of the hepatitis A virus by mechanisms that do not involve severe damage to the liver.

"This is quite an unusual discovery," said Dr. Walker, also a faculty member at The Ohio State University College of Medicine. "These findings document a previously unappreciated role for CD4+ T cells in resolving acute hepatitis A, and perhaps in surveillance against a relapse in virus growth and liver disease that sometimes occurs in those with weak immune systems, particularly the very young and old."

If CD4+ T cells are found to play a similar role in humans, they could serve as a new target for preventing relapse of hepatitis A virus infection. An inefficient helper T cell response might explain why some patients relapse after clearing the infection.

"If CD4+ T cells have an immune surveillance function, as suggested by our findings, patients at greatest risk of relapsing liver disease may benefit from a vaccine that would boost helper T cell activity until the virus is finally cleared from the liver," said Dr. Walker.


'/>"/>

Contact: Mary Ellen Peacock
maryellen.peacock@nationwidechildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Related medicine news :

1. Cedars-Sinai researchers, with stem cells, advance understanding of spinal muscular atrophy
2. New candidate drug stops cancer cells, regenerates nerve cells
3. Glucose deprivation activates feedback loop that kills cancer cells, UCLA study shows
4. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
5. U.S. Sees Tripling of Babies Born Addicted to Painkillers
6. Kids Most Likely to Start Abusing Painkillers at 16: Study
7. Commonly used painkillers may protect against skin cancer
8. Common Painkillers May Help Prevent Skin Cancer: Study
9. Killer stainless steel: New process gives icon of cleanliness antibacterial coating
10. Mental Health Woes Raise Odds for Prescription Painkiller Abuse
11. Genes May Influence Reactions to Painkillers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: